EXCLUSIVE: Biocon biosimilars consolidation rationale; Kiran Mazumdar Shaw decodes capex cycle, R&D costs and global play

Biocon Biologics Merger with Biocon: Biocon is constituting a Governance Council chaired by Kiran Mazumdar-Shaw and a transition and integration management committee, led by Biocon Biologics CEO and MD Shreehas Tambe, to ensure a seamless integration.